Oculis Ownership | Who Owns Oculis?


OverviewForecastChart

Oculis Ownership Summary


Oculis is owned by 8.50% institutional investors, 3.61% insiders, and 87.90% retail investors. Eqt fund management s.a r.l. is the largest institutional shareholder, holding 10.54% of OCS shares.

OCS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOculis8.50%3.61%87.90%
SectorHealthcare Stocks 35.34%11.88%52.77%
IndustryBiotech Stocks 35.37%11.83%52.80%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Eqt fund management s.a r.l.5.90M10.54%$156.89M
Abrdn1.75M3.12%$46.45M
Pivotal bioventure partners investment advisor1.68M3.00%$44.68M
Wellington management group llp1.35M2.40%$35.78M
Millennium management913.03K1.63%$24.28M
Adage capital partners gp833.21K1.49%$22.16M
Sr one capital management, lp641.02K1.14%$17.04M
Saturn v capital management516.76K0.92%$13.74M
Perceptive advisors493.83K0.88%$13.13M
Eventide asset management430.00K0.77%$11.43M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pivotal bioventure partners investment advisor1.68M15.97%$44.68M
Eqt fund management s.a r.l.5.90M15.37%$156.89M
Nan fung group350.75K7.69%$9.33M
Saturn v capital management516.76K2.49%$13.74M
Propel bio management122.22K2.07%$3.28M
Sr one capital management, lp641.02K1.86%$17.04M
Acuta capital partners98.34K1.84%$2.61M
Syquant capital sas222.87K0.93%$5.93M
Perceptive advisors493.83K0.26%$13.13M
Eventide asset management430.00K0.19%$11.43M

Top Buyers

HolderShares% AssetsChange
Millennium management913.03K0.01%897.39K
Adage capital partners gp833.21K0.03%833.21K
Eventide asset management430.00K0.19%430.00K
Folketrygdfondet319.56K0.15%136.76K
Hrt financial lp148.02K0.01%104.11K

Top Sellers

HolderShares% AssetsChange
Pivotal bioventure partners investment advisor1.68M15.97%-608.38K
Nan fung group350.75K7.69%-163.96K
Neo ivy capital management---54.77K
Propel bio management122.22K2.07%-50.62K
Marshall wace, llp---45.77K

New Positions

HolderShares% AssetsChangeValue
Adage capital partners gp833.21K0.03%833.21K$22.16M
Eventide asset management430.00K0.19%430.00K$11.43M
Jane street group90.16K0.00%90.16K$2.40M
Goldman sachs group67.75K0.00%67.75K$1.80M
Point72 asset management56.13K0.00%56.13K$1.49M

Sold Out

HolderChange
Sbi securities-1.00
China universal asset management-2.00K
Gsa capital partners llp-13.04K
Two sigma investments, lp-24.44K
Renaissance-25.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202615-63.41%4,756,937-73.68%80.72%7-77.42%4-
Dec 31, 202541105.00%18,075,56065.92%348.02%31520.00%4-42.86%
Sep 30, 202520-13.04%10,893,907113.37%2021.69%5-61.54%7133.33%
Jun 30, 20252315.00%5,105,6462.56%99.18%13-27.78%3200.00%
Mar 31, 20252066.67%4,978,44042.50%1013.80%18125.00%1-

OCS Ownership FAQ


Who Owns Oculis?

Oculis shareholders are primarily institutional investors at 8.50%, followed by 3.61% insiders and 87.89% retail investors. The average institutional ownership in Oculis's industry, Biotech Stocks , is 35.37%, which Oculis falls below.

Who owns the most shares of Oculis?

Oculis’s largest shareholders are Eqt fund management s.a r.l. (5.9M shares, 10.54%), Abrdn (1.75M shares, 3.12%), and Pivotal bioventure partners investment advisor (1.68M shares, 3.00%). Together, they hold 16.66% of Oculis’s total shares outstanding.

Does Blackrock own Oculis?

BlackRock is not among the top 10 institutional shareholders of Oculis.

Who is Oculis’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Oculis’s biggest shareholder by percentage of total assets invested, with 15.97% of its assets in 1.68M Oculis shares, valued at 44.68M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools